SuperworthAspen Aerogels ASPN
- Market cap
- $458.1M
- PE
- n/m
- a loss over the last year
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 2.3×
- EV/EBIT
- n/m
- a loss over the last year
- Revenue, 12 months
- $202.1M
- −49% on a year ago
- Net margin
- −62.4%
- Free cash flow yield
- 7.5%
Aspen Aerogels trades at 2.3× sales. Its trailing earnings are negative, so it has no PE. Revenue was $202.1M over the last twelve months, down 49% on a year earlier with a −62% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $60.8M+66% | $84.2M+41% | $94.5M+107% | $117.8M+145% | $117.3M+93% | $123.1M+46% | $78.7M−17% | $78M−34% | $73M−38% | $41.3M−66% | $37.9M−52% | $49.8M−36% | |
| Cost of revenue | $46.9M+9% | $54.6M+21% | $59.4M+47% | $66.2M+67% | $68.3M+46% | $76M+39% | $55.9M−6% | $52.7M−20% | $52.2M−24% | $64.3M−15% | $33.6M−40% | $46.6M−12% |
| Gross profit | $13.8M | $29.6M+107% | $35.1M+591% | $51.6M+514% | $49M+255% | $47.1M+59% | $22.8M−35% | $25.3M−51% | $20.8M−58% | −$22.9M | $4.3M−81% | $3.3M−87% |
| R&D | $4.2M−10% | $4.1M−3% | $4.5M+10% | $4.6M+15% | $4.6M+9% | $4.4M+8% | $4.3M−4% | $3.8M−17% | $2.5M−46% | $2.8M−37% | $2.7M−37% | $3.2M−16% |
| SG&A | $24.2M+40% | $24.2M+22% | $25.5M+28% | $27M+26% | $27.1M+12% | $27.2M+13% | $21.4M−16% | $20.8M−23% | $20.1M−26% | $21.7M−20% | $22M+3% | $19.9M−4% |
| −$14.6M−48% | $1.4M | $2.4M | $20M | $17.4M | $14.7M+964% | −$299.3M | −$5.2M | −$3.3M | −$70.4M | −$20.8M−93% | −$28.8M+458% | |
| Interest expense | −$1.9M+12% | −$2.9M+188% | −$3M+1005% | −$3M+1342% | −$1.5M−24% | $0 | $2M | $3.1M | n/a | n/a | $3.2M+61% | $2.8M−10% |
| Pre-tax income | −$13.1M | −$519K | −$1.1M−94% | $17.7M | −$12.7M−3% | $11.2M | −$300.2M+27720% | −$8.2M | −$5.7M−55% | −$73M | −$23.9M−92% | −$22.6M+175% |
| n/a | n/a | $756K | $866K | $267K | −$175K | $1.1M+42% | $821K−5% | $594K+123% | −$97K−45% | −$253K | $619K−25% | |
| Net income | −$13.1M−56% | −$519K−95% | −$1.8M−89% | $16.8M | −$13M−1% | $11.4M | −$301.2M+16317% | −$9.1M | −$6.3M−51% | −$72.9M | −$23.7M−92% | −$23.3M+157% |
| −$0.19−75% | −$0.01−95% | −$0.02−92% | $0.21 | −$0.17−11% | $0.14 | −$3.67+18250% | −$0.11 | −$0.08−53% | −$0.88 | −$0.29−92% | −$0.28+155% | |
| 69.3M+75% | 70M+42% | 75.8M+10% | 79M+14% | 76.3M+10% | 83.8M+20% | 82.1M+8% | 82.2M+4% | 82.4M+8% | 82.7M−1% | 82.7M+1% | 82.9M+1% |
Revenue: Q1 FY13 and Q1 FY14: 6 months less the 3 months printed beside them.
Cost of revenue: Q1 FY13 and Q1 FY14: 6 months less the 3 months printed beside them.
Gross profit: Q1 FY14: 6 months less the 3 months printed beside them.
R&D: Q1 FY13 and Q1 FY14: 6 months less the 3 months printed beside them.
SG&A: Q1 FY13 and Q1 FY14: 6 months less the 3 months printed beside them.
Operating income: Q1 FY14: 6 months less the 3 months printed beside them.
Interest expense: Q1 FY13: 6 months less the 3 months printed beside them.
Net income: Q1 FY13 and Q1 FY14: 6 months less the 3 months printed beside them.
EPS, diluted: 7 periods, Q1 FY13 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: Q1 FY13: share-days: the 6-month average less the second quarter's. 11 periods, Q4 FY13 to Q4 FY25: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days. Q4 FY15 and Q4 FY24: share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Industrial - Distribution nearest Aspen Aerogels' size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| ASPNAspen Aerogels | $458.1M | n/m | 38.8× | 2.3× | −49% | −62.4% | |
| AENTAlliance Entertainment | $516.1M | 17.9× | 21.5× | 0.4× | +8% | 1.1% | |
| FSTRFoster L B | $370.2M | 33.5× | 35.6× | 0.7× | +10% | 2.0% | |
| WLFCWillis Lease Finance | $824.4M | 9.8× | 8.6× | 1.1× | +17% | 12.0% | |
| HDSNHudson Technologies | $226M | 26.9× | 14.1× | 0.9× | +14% | 3.5% | |
| GOLDGold.com | $1.1B | 13.2× | 6.0× | 0.0× | +132% | 0.3% | |
| DSGRDistribution Solutions | $1.6B | 184× | 41.3× | 0.8× | +6% | 0.4% | |
| GICGLOBAL INDUSTRIAL | $1.7B | 19.8× | 17.5× | 1.2× | +8% | 6.1% | |
| DXPEDXP Enterprises | $2.4B | 27.5× | 19.0× | 1.1× | +11% | 4.4% | |
| REZIResideo Technologies | $2.7B | 7.5× | 10.6× | 0.4× | +3% | 5.6% | |
| BCCBOISE CASCADE | $2.7B | 26.4× | 11.8× | 0.4× | −2% | 1.6% | |
| Peer median | $1.4B | 23.1× | 15.8× | 0.7× | +9% | 2.8% |
More on Aspen Aerogels
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
Its groups
About
- Industry
- Industrial - Distribution
- Sector
- Industrials
Valuation data, not investment advice. Prices as of .